Prosecution Insights
Last updated: April 19, 2026

Wuxi Biologics Ireland Limited

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19210620 PSMA ANTIBODIES AND USES THEREOF GEORGE, DENNIS CHERIAN 1644 Non-Final OA May 16, 2025
18282767 A BISPECIFIC ANTI-PD-L1/VEGF ANTIBODY AND USES THEREOF JOHANSEN, PETER N. 1644 Non-Final OA Sep 18, 2023
17996441 A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTEIN HAVING A MANNOSE-TERMINATED N-GLYCAN MULDER, SCOTT EVAN 1656 Final Rejection Oct 18, 2022

Managing Wuxi Biologics Ireland Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month